Trials / Recruiting
RecruitingNCT06483373
A Clinical Study of SPH7854 Granules in Healthy Subjects.
A Single and Multiple Dose-escalation, and Food Effects of Phase I Clinical Study to Evaluate the Tolerability/Safety/Pharmacokinetics of SPH7854 Granules in Healthy Subjects.
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 111 (estimated)
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety of SPH7854 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPH7854 | SPH7854： Orally, 50-3200mg |
| DRUG | Placebo | Placebo：Orally； |
Timeline
- Start date
- 2024-05-28
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2024-07-03
- Last updated
- 2025-08-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06483373. Inclusion in this directory is not an endorsement.